This dataset contains summary data visualizations and clinical data for a list of oncogenic and likely oncogenic alterations in 413 samples in tumors of the bladder from 412 patients, gathered as part of a comprehensive molecular characterization of muscle-invasive bladder cancer. Clinical data includes mutation count, information about mutated genes, patient demographics, and American Joint Committee...

Summary from the GEO: "RNA-sequencing of a panel of urothelial cancer cells. The goal of the study is to examine the genome-wide expression profile in each of the 30 urothelial cancer cells tested in our laboratory." "Overall design: Each of the 30 cell lines was DNA fingerprinted to confirm its real identity. Total RNA was obtained from each cell line and subjected to Illumina RNA sequencing."...

This dataset contains summary data visualizations and clinical data from a broad sampling of HER2- and HER3-mutant tumors. The data was generated utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK), mutation count, information about mutated genes, Amplification Status, Best objective response rate, Bubble...

This dataset contains summary data visualizations and clinical data from whole-exome or targeted sequencing of 476 muscle-invasive bladder tumor/normal pairs via TCGA or MSK-IMPACT sequencing from 476 patients. The clinical data includes Mutation Count, Fraction Genome Altered, patient demographics, MSI scores, AJCC Metastasis Stage Code, AJCC Neoplasm Disease Lymph Node Stage, AJCC Neoplasm Disease...

This dataset contains the summary data visualizations and clinical data from MSK-IMPACT sequencing of 105 High Risk Nonmuscle Invasive Bladder Cancer samples from 105 patients. Clinical data includes: Mutation Count, Fraction Genome Altered, Diagnosis Age, Sex, Concomitant Carcinoma in situ, Number of Tumors, Recurrence, Specimen Type, Stage, Treatment, Tumor Size. The plaintext components of the...